TCF4 and breast carcinoma: In line with our results, a previous study, using targeted sequencing in a PDX-based modeling of breast cancer chemoresistance, identified a genomic variant of ITF2 that depicted a link between its altered expression and breast cancer chemoresistance, although no detailed mechanism was provided to connect ITF2 function to chemoresistance [22].